Does BARICITINIB Cause Hyperlipidaemia? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperlipidaemia have been filed in association with BARICITINIB (Olumiant). This represents 0.1% of all adverse event reports for BARICITINIB.
11
Reports of Hyperlipidaemia with BARICITINIB
0.1%
of all BARICITINIB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Hyperlipidaemia From BARICITINIB?
Of the 11 reports, 6 (54.5%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
Yes, Hyperlipidaemia is listed as a known adverse reaction in the official FDA drug label for BARICITINIB.
What Other Side Effects Does BARICITINIB Cause?
Drug ineffective (569)
Off label use (479)
Covid-19 (347)
Pulmonary embolism (288)
Rheumatoid arthritis (284)
Headache (216)
Herpes zoster (216)
Pneumonia (216)
Death (206)
Deep vein thrombosis (201)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which BARICITINIB Alternatives Have Lower Hyperlipidaemia Risk?
BARICITINIB vs BARIUM
BARICITINIB vs BARNIDIPINE
BARICITINIB vs BASILIXIMAB
BARICITINIB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BARICITINIB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED